MedTrace Logo

Progression of Early Atrophic Lesions

NCT05959005 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 125

Last updated 2026-03-11

No results posted yet for this study

Summary

Early atrophic age-related macular degeneration (AMD) represents an important time window in the course of so far untreatable atrophic AMD, as patients typically experience only some degree of visual dysfunction, while being at significant risk for marked further loss of vision. To allow the precise evaluation of upcoming therapeutic interventions, a better understanding of the manifestation and variable disease progression is needed. This project aims to investigate refined tools to detect and monitor early atrophic AMD more accurately, including the impact on visual dysfunction and quality of life.

Conditions

  • Age-Related Macular Degeneration

Interventions

OTHER

No intervention

There is no intervention.

Sponsors & Collaborators

Principal Investigators

  • Monika Fleckenstein · University of Utah

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-20
Primary Completion
2028-06-30
Completion
2028-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05959005 on ClinicalTrials.gov